GLAXO SEEKING TO RECOVER TOP RANKING IN GLOBAL Rx BUSINESS VIA MERGER WITH SMITHKLINE; AHP LEFT TO CONTEND WITH SPECULATION ABOUT ITS STRATEGIC DIRECTION
Executive Summary
Glaxo is bidding to re-establish its position as the largest pharmaceutical firm in the U.S. and worldwide via its proposed merger with SmithKline Beecham.